Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase... by Kowdley, Kris V, Dr, Lawitz, Eric, MD, Crespo, Israel, MD, Hassanein, Tarek, MD, Davis, Mitchell N, MD, DeMicco, Michael, MD, Bernstein, David E, MD, Afdhal, Nezam, MD, Vierling, John M, MD, Gordon, Stuart C, MD, Anderson, Jane K, PhD, Hyland, Robert H, DPhil, Dvory-Sobol, Hadas, PhD, An, Di, PhD, Hindes, Robert G, MD, Albanis, Efsevia, MD, Symonds, William T, PharmD, Berrey, M Michelle, MD, Nelson, David R, MD, Jacobson, Ira M, MD

Get full text

Slowing the progression of chronic hepatitis B: Early antiviral therapy can help minimize complications by Purow, David B., Jacobson, Ira M.

Get full text

Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response by Gellad, Ziad F., MD, MPH, Muir, Andrew J., MD, MHS, McHutchison, John G., MD, Sievert, William, MD, Sharara, Ala I., MD, Brown, Kimberly A., MD, Flisiak, Robert, MD, Jacobson, Ira M., MD, Kershenobich, David, MD, Manns, Michael P., MD, Schulman, Kevin A., MD, Reed, Shelby D., PhD

Get full text

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and trea... by Lawitz, Eric, Prof, Sulkowski, Mark S, Prof, Ghalib, Reem, MD, Rodriguez-Torres, Maribel, MD, Younossi, Zobair M, Prof, Corregidor, Ana, MD, DeJesus, Edwin, MD, Pearlman, Brian, Prof, Rabinovitz, Mordechai, Prof, Gitlin, Norman, MD, Lim, Joseph K, MD, Pockros, Paul J, MD, Scott, John D, MD, Fevery, Bart, MSc, Lambrecht, Tom, MSc, Ouwerkerk-Mahadevan, Sivi, PhD, Callewaert, Katleen, MSc, Symonds, William T, PharmD, Picchio, Gaston, PhD, Lindsay, Karen L, MD, Beumont, Maria, MD, Jacobson, Ira M, Prof

Get full text

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study by Manns, Michael, Prof, Pol, Stanislas, Prof, Jacobson, Ira M, Prof, Marcellin, Patrick, Prof, Gordon, Stuart C, Prof, Peng, Cheng-Yuan, MD, Chang, Ting-Tsung, Prof, Everson, Gregory T, Prof, Heo, Jeong, Prof, Gerken, Guido, Prof, Yoffe, Boris, Prof, Towner, William J, MD, Bourliere, Marc, MD, Metivier, Sophie, MD, Chu, Chi-Jen, MD, Sievert, William, Prof, Bronowicki, Jean-Pierre, Prof, Thabut, Dominique, Prof, Lee, Youn-Jae, Prof, Kao, Jia-Horng, Prof, McPhee, Fiona, PhD, Kopit, Justin, PhD, Mendez, Patricia, MD, Linaberry, Misti, MPH, Hughes, Eric, MD, Noviello, Stephanie, MD

Get full text

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT... by Kwo, Paul Y, Dr, Lawitz, Eric J, MD, McCone, Jonathan, MD, Schiff, Eugene R, Prof, Vierling, John M, Prof, Pound, David, MD, Davis, Mitchell N, DO, Galati, Joseph S, MD, Gordon, Stuart C, MD, Ravendhran, Natarajan, MD, Rossaro, Lorenzo, Prof, Anderson, Frank H, MD, Jacobson, Ira M, Prof, Rubin, Raymond, MD, Koury, Kenneth, PhD, Pedicone, Lisa D, PhD, Brass, Clifford A, MD, Chaudhri, Eirum, MD, Albrecht, Janice K, PhD

Get full text

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, doubl... by Lawitz, Eric, Prof, Lalezari, Jay P, MD, Hassanein, Tarek, Prof, Kowdley, Kris V, Prof, Poordad, Fred F, Prof, Sheikh, Aasim M, MBBS, Afdhal, Nezam H, Prof, Bernstein, David E, Prof, DeJesus, Edwin, MD, Freilich, Bradley, MD, Nelson, David R, Prof, Dieterich, Douglas T, Prof, Jacobson, Ira M, Prof, Jensen, Donald, Prof, Abrams, Gary A, MD, Darling, Jama M, MD, Rodriguez-Torres, Maribel, MD, Reddy, K Rajender, Prof, Sulkowski, Mark S, Prof, Bzowej, Natalie H, MD, Hyland, Robert H, DPhil, Mo, Hongmei, PhD, Lin, Ming, PhD, Mader, Michael, MS, Hindes, Robert, MD, Albanis, Efsevia, MD, Symonds, William T, PharmD, Berrey, Michelle M, MD, Muir, Andrew, Prof

Get full text

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study by Marcellin, Patrick, Prof, Gane, Edward, Prof, Buti, Maria, Prof, Afdhal, Nezam, Prof, Sievert, William, Prof, Jacobson, Ira M, Prof, Washington, Mary Kay, Prof, Germanidis, George, Prof, Flaherty, John F, PharmD, Schall, Raul Aguilar, PhD, Bornstein, Jeffrey D, MD, Kitrinos, Kathryn M, PhD, Subramanian, G Mani, MD, McHutchison, John G, MD, Heathcote, E Jenny, Prof

Get full text

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double... by Jacobson, Ira M, Prof, Dore, Gregory J, Prof, Foster, Graham R, Prof, Fried, Michael W, Prof, Radu, Monica, MD, Rafalsky, Vladimir V, Prof, Moroz, Larysa, Prof, Craxi, Antonio, Prof, Peeters, Monika, MSc, Lenz, Oliver, PhD, Ouwerkerk-Mahadevan, Sivi, PhD, De La Rosa, Guy, MD, Kalmeijer, Ronald, MD, Scott, Jane, PhD, Sinha, Rekha, PhD, Beumont-Mauviel, Maria, PhD

Get full text

Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies by Rivadeneira, David E, Pochapin, Mark, Grobmyer, Stephen R, Lieberman, Michael D, Christos, Paul J, Jacobson, Ira, Daly, John M

Get full text